This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanxiao Yi: Patent Activity in Ovarian Health
Introduction
Yanxiao Yi is an inventor based in Beijing, China, and is associated with the Chinese Academy of Sciences. His reported patent work concerns a potential approach to preventing or treating ovarian dysfunction diseases.
Latest Patents
Yi is associated with one patent application titled “Use of the Active Compound in the Prevention or Treatment of Ovarian Dysfunction Diseases.” The disclosure describes using a compound represented by Formula I, or a pharmaceutically acceptable salt of that compound, to prevent or treat ovarian dysfunction disease. It also describes combining the compound with hyodeoxycholic acid, or a pharmaceutically acceptable salt thereof, and discusses compositions containing either or both substances. The disclosed Formula I compounds have R1 and R2 groups independently selected from hydrogen, C1–C6 alkyl, C1–C6 alkenyl, and C1–C6 alkynyl groups. Yi’s reported patent count is 1 patent.
Career Highlights
Yi’s listed affiliation with the Chinese Academy of Sciences connects his patent activity to a major research institution. The available information identifies his work in pharmaceutical research focused on ovarian dysfunction.
Collaborations
Cuiling Lu and Ning Zhang are identified as Yi’s coworkers. The supplied information does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Yanxiao Yi’s reported patent activity centers on compounds and compositions proposed for preventing or treating ovarian dysfunction diseases, reflecting a focused contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
